They showed that right-sided colon cancers had higher rates of MSI, more frequent aberrant activation of EGFR pathways, more frequent BRAF and PI3KCA mutations and an increased mutational burden compared to left-sided and rectal cancers [237]. This evidence concerns the gene BRAF and colonic neoplasm.